share_log

B of A Securities Maintains Buy on Kura Oncology, Lowers Price Target to $29

B of A Securities Maintains Buy on Kura Oncology, Lowers Price Target to $29

B of A证券重申对kura oncology的买入评级,将目标股价下调至29美元
Benzinga ·  2024/11/22 07:51  · 评级/大行评级

B of A Securities analyst Jason Zemansky maintains Kura Oncology (NASDAQ:KURA) with a Buy and lowers the price target from $36 to $29.

B of A证券分析师Jason Zemansky维持Kura Oncology(纳斯达克:kura oncology)的买入评级,将目标股价从36美元降至29美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发